Browse the evidence

The brain utilizes two distinct, opponent neural networks to process food cues: a Limbic network that automatically encodes hedonic value (pleasantness/appetite), and a Prefrontal network that encodes regulatory information (healthfulness, processing level, and self-control requirements).

When you see food, your brain automatically splits the information: one part tells you how good it tastes (Limbic), and another tells you how processed/healthy it is (Prefrontal). To make better choices, consciously engage the Prefrontal network by focusing on the food's processing level or health attributes, rather than just fighting the taste. This leverages the brain's natural regulatory architecture.

The semaglutide 2.4 mg single-dose pen-injector (SPI) demonstrates high ease-of-use and acceptability, with the vast majority of participants finding it easy to use and training, and preferring it over daily oral medication.

If you are considering semaglutide 2.4 mg via the single-dose pen, expect it to be easy to use. Most users found the training simple and the injection process easy. While some initial use errors (like seeing liquid on the skin) can occur, they are common in the first few injections and tend to disappear with practice. The device is generally preferred over daily pills due to its weekly frequency and ease of use.

Increasing cardiorespiratory fitness and losing body mass index (BMI) independently and synergistically slow the progression of deficit accumulation frailty (a marker of biological aging) in adults with type 2 diabetes and overweight/obesity.

If you have type 2 diabetes and are overweight, focusing on improving your aerobic fitness (like brisk walking for >175 minutes a week) and losing weight (targeting >7% loss) can significantly slow biological aging. These two actions work independently: improving fitness helps even if you don't lose much weight, and losing weight helps even if your fitness doesn't change much. Doing both provides the greatest benefit. This applies even if you are over 65.

Women with severe obesity and PCOS exhibit significantly higher baseline cognitive restraint eating compared to women with severe obesity without PCOS, yet fail to show favorable alterations in eating behaviors (reduced emotional/uncontrolled eating, increased cognitive restraint) after a 12-month structured weight loss intervention, unlike their non-PCOS counterparts.

If you have PCOS and severe obesity, you can lose significant weight (12-14 kg) with a structured intervention, just like women without PCOS. However, standard dietary restriction alone may not change your eating habits (emotional or uncontrolled eating) as effectively. You likely need targeted behavioral support to address emotional eating, not just calorie counting, to maintain the weight loss.

Brief GP-delivered weight loss advice (approx. 86 seconds) results in a statistically significant mean weight loss of 1.04 kg at 12 months compared to a baseline population average of ~300g, demonstrating that the intervention itself, rather than specific behavioral change techniques (BCTs), drives the outcome.

As a primary care clinician, you do not need extensive training or long consultations to help patients with obesity lose weight. Simply delivering a brief, opportunistic piece of advice (around 1.5 minutes) at the end of a routine visit is sufficient to motivate patients to take action and achieve a modest but significant weight loss (approx. 1 kg) over a year. Focus on the act of advising rather than perfecting specific behavioral techniques.

The use of the Behavioral Change Technique 'Feedback on outcomes of behaviour (future)' significantly increases the likelihood of patients taking action to lose weight by 12 months (OR=6.10), although it does not directly correlate with greater mean weight loss.

When giving brief weight loss advice, explicitly schedule a follow-up appointment or promise to provide feedback on the patient's weight in the future. This specific technique ('Feedback on outcomes of behaviour (future)') makes patients significantly more likely to take action (e.g., diet/exercise changes) within a year, even if the total weight loss isn't drastically different from other methods.

Psychosocial factors (confidence, social support, emotional eating) and metabolic status are stronger predictors of weight loss success in behavioral obesity treatment than diet type (low-fat vs. low-carb) or demographic variables alone.

If you are starting a weight loss program, your success is less about whether you choose low-fat or low-carb and more about your mindset and environment. Assess your confidence in sticking to the plan, manage emotional eating, and ensure your social circle is supportive. If you struggle with emotional eating, seek specific psychological support alongside dietary changes.

Resistance training does not reduce flexibility; this is a common myth.

You do not need to fear that lifting weights will make you stiff. Resistance training, when performed through a full range of motion, does not reduce flexibility and can be part of a balanced fitness routine.

In overweight or obese adults with type 2 diabetes, intensive lifestyle intervention (ILI) eliminates the association between weight variability and increased risk of major adverse cardiovascular events (MACE), whereas without ILI, high weight variability significantly increases MACE risk.

If you have type 2 diabetes and are overweight, do not avoid weight loss because you are afraid of weight fluctuations. Engage in a structured, intensive lifestyle program (diet and exercise counseling). This paper shows that the weight changes resulting from such a program do not increase your risk of heart events, unlike unmanaged weight variability.

A 10-year multidomain intensive lifestyle intervention (ILI) targeting weight loss, physical activity, and diet in individuals with type 2 diabetes and obesity results in sustained long-term weight loss and lower deficit accumulation (frailty) compared to diabetes support and education (DSE), though it does not significantly improve composite cognitive function scores.

For older adults with type 2 diabetes, a structured lifestyle program focusing on diet, exercise, and regular monitoring can help maintain weight loss and reduce physical frailty over the long term, even if it doesn't necessarily improve cognitive function scores. The key is consistency and metabolic monitoring.

A high-carbohydrate diet (79% carbs) does not improve hedonic regulation (liking/wanting) of food intake compared to high-fat or control diets, though it may increase subjective satiety due to fiber content.

Eating a high-carbohydrate diet may make you feel more full due to fiber content, but it does not change your psychological desire (liking/wanting) for food compared to high-fat or balanced diets.

Performing resistance training to momentary muscular failure (FAIL) results in slightly greater perceived discomfort and exertion, and worsens general post-exercise feelings compared to terminating sets with 1-2 repetitions in reserve (RIR).

If you are struggling to stick to your resistance training routine because you hate how you feel after workouts, try stopping your sets 1-2 reps before you fail (1-2 RIR) instead of going to absolute failure. This study found that while muscle growth and strength gains are similar, training to failure significantly increases discomfort, exertion, and negative feelings. By using 1-2 RIR, you get the same physical benefits with better post-workout feelings, which may help you stay consistent long-term.

Higher doses of orforglipron (36-45 mg) are associated with increased treatment discontinuation due to adverse events compared to lower doses and placebo.

Higher doses of orforglipron work better for weight loss but cause more side effects, leading some people to stop taking it. If you struggle with side effects, ask your doctor about a lower dose (24-36 mg) which may be easier to tolerate.

Insomnia and insufficient sleep duration are independent cardiovascular risk factors that should be addressed alongside OSA.

If you have sleep apnea but also struggle with insomnia or don't get enough sleep, treating those issues is just as important for your heart as using your CPAP. Ask your doctor about Cognitive Behavioral Therapy for Insomnia (CBTi), which is the gold standard treatment for insomnia.

For patients with poorly controlled type 2 diabetes on basal insulin, using FreeStyle Libre (FSL) continuous glucose monitoring systems reduces overall lifetime healthcare costs and increases quality-adjusted life years (QALYs) compared to self-blood glucose monitoring (SBGM).

If you have type 2 diabetes, take basal insulin, and your blood sugar is not well controlled (HbA1c > 8%), switching from finger-prick testing to a flash glucose monitor (like FreeStyle Libre) is likely to save your healthcare system money and improve your long-term health and quality of life. This is because it helps prevent dangerous low blood sugar events and long-term complications like heart disease or kidney failure, while also being less painful and inconvenient than daily finger pricks.

Implementing enhanced nurse care manager (NCM) training and digital monitoring tools in primary care significantly increases patient enrollment in online behavioral weight loss programs compared to basic implementation, without compromising weight loss outcomes or program acceptability.

For primary care systems, simply offering an online weight loss program is not enough. You must invest in 'Enhanced' implementation strategies: train your care managers in motivational interviewing, provide them with a dashboard that flags non-adhering patients, and encourage proactive follow-up calls. This approach significantly increases the number of patients who start the program, which is the biggest hurdle in obesity treatment, even if it doesn't change the weight loss results for those who do start.

Baseline sleep disturbance significantly moderates the efficacy of behavioral weight loss interventions in breast cancer survivors, with poor sleepers achieving significantly less weight loss than better sleepers.

If you are a breast cancer survivor trying to lose weight, your sleep quality matters as much as your diet. If you have poor sleep, standard weight loss programs may be half as effective for you. Consider getting your sleep evaluated and treated before or during your weight loss journey to maximize results.

Resistance-trained individuals have acceptable baseline accuracy in estimating Repetitions in Reserve (RIR), and this accuracy improves further when using a varying proximity-to-failure protocol (RIR 4-1).

If you are an experienced lifter, you can trust your ability to estimate how many reps you have left in the tank (RIR). You don't need to start from scratch. Using a training program that varies your intensity (starting easier and getting harder) can actually help you get better at estimating RIR, making your training more precise and effective.

Progressive increases in resistance training volume (weekly sets) linearly increase perceptual strain and monotony, but these perceptual metrics do not predict muscle hypertrophy (muscle thickness).

If you are increasing your weekly training sets, expect your perceived strain and monotony to go up. However, do not assume that this increased strain will lead to more muscle growth. The study found no link between how hard you perceive the training to be and actual muscle thickness gains. Focus on managing volume to avoid non-functional overreaching rather than chasing high strain as a proxy for hypertrophy.

Early weight loss trajectory (first 14 days) and recording frequency can predict long-term weight loss patterns, with shallow initial loss and infrequent logging predicting a 'plateau-then-increase' pattern.

Track your weight daily for the first two weeks. If you aren't losing weight or are skipping logs, you are statistically likely to hit a plateau and regain weight later. Use this early data to adjust your habits immediately rather than waiting months to see if it works.

Perceived success in weight loss maintenance is a stronger predictor of satisfaction and continued physical activity engagement than quantitative weight loss metrics alone.

Don't just focus on the scale. If you don't *feel* like you've succeeded, you're less likely to stay active and satisfied, even if you've lost weight. Align your goals with how you want to feel and function, not just a percentage of weight loss.

Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring systems improve glycemic control and reduce hypoglycemia risk in patients with Type 2 Diabetes, particularly those on insulin therapy.

If you have Type 2 Diabetes and are on insulin, ask your doctor about Continuous Glucose Monitoring (CGM) or Flash Glucose Monitoring systems. These devices provide real-time data on your blood sugar levels and trends, helping you and your doctor adjust your insulin doses more precisely and safely, reducing the risk of dangerous lows.

Both intensive behavioral group intervention and brief individual counseling result in small, similar weight loss over 5 years, suggesting that regular follow-up and person-centered care may promote weight maintenance.

Regular medical check-ins and basic dietary advice can help maintain weight in middle age. You do not necessarily need complex programs to achieve modest, sustainable results.

Patient preferences for GLP-1 receptor agonist outcomes vary substantially by demographic factors (age, sex, BMI), with younger individuals and women expressing significantly higher concern regarding cosmetic side effects like alopecia and severe gastrointestinal outcomes compared to older men.

If you are considering GLP-1 medication, your personal tolerance for side effects matters more than the average patient's experience. Younger women, in particular, may find hair loss or GI issues more distressing than older men. Discuss these specific fears with your doctor before starting, as they significantly impact whether you will stick with the treatment long enough to see benefits.